[go: up one dir, main page]

GB201517565D0 - Treatment of genetic diseases - Google Patents

Treatment of genetic diseases

Info

Publication number
GB201517565D0
GB201517565D0 GBGB1517565.6A GB201517565A GB201517565D0 GB 201517565 D0 GB201517565 D0 GB 201517565D0 GB 201517565 A GB201517565 A GB 201517565A GB 201517565 D0 GB201517565 D0 GB 201517565D0
Authority
GB
United Kingdom
Prior art keywords
treatment
genetic diseases
genetic
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1517565.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ProQR Therapeutics II BV
Original Assignee
ProQR Therapeutics II BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ProQR Therapeutics II BV filed Critical ProQR Therapeutics II BV
Priority to GBGB1517565.6A priority Critical patent/GB201517565D0/en
Publication of GB201517565D0 publication Critical patent/GB201517565D0/en
Priority to EP16779049.2A priority patent/EP3359667A1/en
Priority to AU2016335032A priority patent/AU2016335032B2/en
Priority to KR1020187011879A priority patent/KR20180053753A/en
Priority to US15/765,864 priority patent/US10760076B2/en
Priority to JP2018536344A priority patent/JP7089763B2/en
Priority to PCT/EP2016/073817 priority patent/WO2017060317A1/en
Priority to CN201680058611.9A priority patent/CN108291225B/en
Priority to CA3000061A priority patent/CA3000061C/en
Priority to US16/983,129 priority patent/US20200362348A1/en
Priority to JP2022016668A priority patent/JP2022070913A/en
Ceased legal-status Critical Current

Links

GBGB1517565.6A 2015-10-05 2015-10-05 Treatment of genetic diseases Ceased GB201517565D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB1517565.6A GB201517565D0 (en) 2015-10-05 2015-10-05 Treatment of genetic diseases
CA3000061A CA3000061C (en) 2015-10-05 2016-10-05 Use of single-stranded antisense oligonucleotide in prevention or treatment of genetic diseases involving a trinucleotide repeat expansion
US15/765,864 US10760076B2 (en) 2015-10-05 2016-10-05 Use of single-stranded antisense oligonucleotide in prevention or treatment of genetic diseases involving a trinucleotide repeat expansion
AU2016335032A AU2016335032B2 (en) 2015-10-05 2016-10-05 Use of single-stranded antisense oligonucleotide in prevention or treatment of genetic diseases involving a trinucleotide repeat expansion
KR1020187011879A KR20180053753A (en) 2015-10-05 2016-10-05 Use of single-stranded antisense oligonucleotides for the prevention or treatment of genetic diseases associated with trinucleotide repeat extension
EP16779049.2A EP3359667A1 (en) 2015-10-05 2016-10-05 Use of single-stranded antisense oligonucleotide in prevention or treatment of genetic diseases involving a trinucleotide repeat expansion
JP2018536344A JP7089763B2 (en) 2015-10-05 2016-10-05 Use of single-stranded antisense oligonucleotides in the prevention or treatment of genetic disorders involving trinucleotide repeat elongation
PCT/EP2016/073817 WO2017060317A1 (en) 2015-10-05 2016-10-05 Use of single-stranded antisense oligonucleotide in prevention or treatment of genetic diseases involving a trinucleotide repeat expansion
CN201680058611.9A CN108291225B (en) 2015-10-05 2016-10-05 Use of single-stranded antisense oligonucleotides for preventing or treating genetic diseases involving repeated amplification of trinucleotide
US16/983,129 US20200362348A1 (en) 2015-10-05 2020-08-03 Use of single-stranded antisense oligonucleotide in prevention or treatment of genetic diseases involving a trinucleotide repeat expansion
JP2022016668A JP2022070913A (en) 2015-10-05 2022-02-04 Use of single-stranded antisense oligonucleotides in prevention or treatment of genetic diseases involving trinucleotide repeat expansion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1517565.6A GB201517565D0 (en) 2015-10-05 2015-10-05 Treatment of genetic diseases

Publications (1)

Publication Number Publication Date
GB201517565D0 true GB201517565D0 (en) 2015-11-18

Family

ID=54606100

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1517565.6A Ceased GB201517565D0 (en) 2015-10-05 2015-10-05 Treatment of genetic diseases

Country Status (1)

Country Link
GB (1) GB201517565D0 (en)

Similar Documents

Publication Publication Date Title
IL290980A (en) Rna for treatment of autoimmune diseases
IL323562A (en) Methods of treating inflammatory diseases
IL253244A0 (en) Methods of treating retinal diseases
LT3122878T (en) Mrna therapy for the treatment of ocular diseases
IL257561A (en) Methods of treating inflammatory diseases
ZA201903003B (en) Treatment of neurological diseases
EP4591936A3 (en) Treatment of respiratory diseases
GB201516905D0 (en) Treatment of Neurodegenerative diseases
GB201412578D0 (en) Treatment of neurological diseases
ZA201705877B (en) Method of treating diseases
EP3340974A4 (en) Methods for treatment of diseases
IL253847A0 (en) Methods of treating diseases
SI3302499T1 (en) Treatment of mitochondrial diseases
PL3182980T3 (en) Treatment of glycosylation deficiency diseases
EP3242662A4 (en) Treatment of filarial diseases
GB201512139D0 (en) Methods of treatment
GB201517565D0 (en) Treatment of genetic diseases
GB201604253D0 (en) Treatment of genetic diseases
GB201514909D0 (en) Treatment of autoimmune diseases
GB201621398D0 (en) Treatment of emt-associated disease
GB201504413D0 (en) Treatment of disease
GB201414023D0 (en) Treatment of autoimmune diseases
AU2015901032A0 (en) Treatment of respiratory diseases
GB201501800D0 (en) Treatment of medical conditions

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)